10x Genomics, Inc. (TXG)

NASDAQ

$71.61

$+1.69

(+2.42%)

Previous Close: ⁦$69.75⁩

Market Closed

10x Genomics, Inc. (TXG) Live Price Chart

Last updated: ⁦2026-10-24 01:45:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

10x Genomics, Inc. (TXG) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $71.61, with a market capitalization of $9.85B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.25 to $102.81. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$9.85B
Open	$68.94
Day's High	$208.99
Day's Low	$6.78
Previous Close	$69.75
Volume	1.86M
Average Volume	3.37M
P/E Ratio	--
52-Week High	$102.81
52-Week Low	$12.25
Dividend Yield	--
Earnings Date	--

10x Genomics, Inc. (TXG) Latest Closing Stock Price

10x Genomics, Inc. (TXG) last closed at $69.75 as of 2026-10-23 23:34:00, unchanged from the previous close of $69.75.

During the latest regular trading session, TXG traded between $6.78 and $208.99, with a volume of 1.86M shares. The closing price was near the lower end and near the middle of its 52-week range.

10x Genomics, Inc. (TXG) 7-Day Stock Price Change

Over the past seven days, 10x Genomics, Inc. (TXG) moved from $73.10 to $71.61, representing a decline of 2.04% ($1.49).

The stock traded between $67.25 and $77.55 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 3.51 million shares, down versus the previous seven-day period, indicating lower trading activity.

TXG 52-Week Price Position

Position in Range: 65.5%

52W Low$12.25

52W High$102.81

TXG is currently trading at $71.61, placing it 65.5% of the way from its 52-week low of $12.25 to its 52-week high of $102.81. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is 10x Genomics, Inc. (TXG)?

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

10x Genomics, Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	1178
Exchange	NASDAQ
Company Website	https://www.10xgenomics.com

How to Buy 10x Genomics, Inc. (TXG) Stock on MEXC

Eligible investors can buy real shares of 10x Genomics, Inc. (TXG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TXG and Place Your Order

Open the RealStocks trading page and search for TXG. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is 10x Genomics, Inc. (TXG) stock price today?

10x Genomics, Inc. (TXG) is currently trading at $ 71.61, up 2.66% ($1.86) from the previous close of $ 69.75. Intraday prices update in real time during regular trading hours.

2.Is TXG stock going up or down today?

As of 2026-10-23 23:34:00, TXG is trading at $ 71.61, up 2.66% ($1.86) from its previous close of $ 69.75. The stock has traded between $ 6.78 and $ 208.99 during today’s regular session. Past price movements do not guarantee future results.

3.What is TXG pre-market price?

As of 2026-10-23 23:34:00, TXG is trading at $ 69.79 in pre-market trading, up 0.05% ($0.03) from the previous close of $ 69.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TXG after-hours price?

As of 2026-10-23 23:34:00, TXG is trading at $ 71.37 in after-hours trading, up 2.32% ($1.62) from the regular-session close of $ 69.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TXG stock trading now?

TXG trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TXG sit relative to its 52-week high and low?

Over the past 52 weeks, TXG has traded between a low of $ 12.25 and a high of $ 102.81. At $ 71.61, the stock is positioned 65.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is 10x Genomics, Inc. in?

10x Genomics, Inc. (TXG) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is 10x Genomics, Inc.'s market capitalization and where is it listed?

10x Genomics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 9.85B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TXG valued in terms of P/E ratio and EPS?

TXG trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.58. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does 10x Genomics, Inc. pay a dividend?

10x Genomics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.